Biological delivery, biologically

NanoSyrinx is a discovery stage synthetic biology company creating a next-generation platform technology for the targeted intracellular delivery of biological molecules. Most drugs do not traverse the body well, limiting their effectiveness. This is an even greater problem for biologic drugs, such as antibodies and peptides; and consequently new delivery modalities are sorely needed.

Our vision at NanoSyrinx is to unlock the interior of the cell and the myriad therapeutic opportunities within that are currently difficult (or impossible) to drug, by enabling targeted, intracellular delivery of protein therapeutics.

Building on over a decade of fundamental research, our scientists are harnessing the unique properties of Nature’s own elegant solution to the intracellular bioavailability problem.